From DCAT Value Chain Insights (VCI)
Innophos Holdings, Inc., a provider of specialty ingredients, has appointed Kim Ann Mink, PhD, as chief executive officer (CEO) and president, effective December 14, 2015. Dr. Mink succeeds Randy Gress, who is retiring from the company after eleven years of service. Mr. Gress will continue to serve as chairman during a transition period, expected to last approximately three months. After the transition period, the company said Mr. Gress will step down as chairman and director, and it expects Dr. Mink will be appointed to the board of directors.
Dr. Mink has been business president of elastomers, electrical and telecommunications at The Dow Chemical Company since September 2012. Dr. Mink joined Dow in April 2009 as global general manager, performance materials and president/CEO ANGUS Chemical Co. (then a fully owned subsidiary of Dow Chemical). Prior to joining Dow, Dr. Mink was corporate vice president and global general manager, ion exchange resins at the Rohm and Haas Company (now a fully owned subsidiary of Dow), where she spent more than 20 years serving in numerous senior roles with increasing responsibilities.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription